Showing results (181-190 of 330) with videos related to

Sort By:
Pageof 33
Biomaterials|July 6, 2015
Biodegradable nano-films for capture and non-invasive release of circulating tumor cellsWei Li, Eduardo Reátegui, Myoung-Hwan Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I TrialKenneth S Thress, Vivien Jacobs, Helen K Angell, et al.
Frontiers in Microbiology|June 8, 2018
Vancomycin and/or Multidrug-Resistant Citrobacter Freundii Altered the Metabolic Pattern of Soil Microbial CommunityMariusz Cycoń, Kamila Orlewska, Anna Markowicz, et al.
ACS Applied Bio Materials|January 13, 2022
Toward the Development of an Innovative Implant: NiTi Alloy Functionalized by Multifunctional β-TCP+Ag/SiO2 CoatingsMateusz Dulski, Karolina Dudek, Damian Chalon, et al.
JCO Precision Oncology|October 30, 2018
Clinical Utility of Rapid EGFR Genotyping in Advanced Lung CancerIbiayi Dagogo-Jack, Christopher G Azzolli, Florian Fintelmann, et al.
Journal of Bacteriology|July 11, 2002
Functional characterization of Gne (UDP-N-acetylglucosamine-4-epimerase), Wzz (chain length determinant), and Wzy (O-antigen polymerase) of Yersinia enterocolitica serotype O:8José Antonio Bengoechea, Elise Pinta, Tiina Salminen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and HMatthew A Gubens, Lecia V Sequist, James P Stevenson, et al.
JTO Clinical and Research Reports|February 25, 2025
Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITYJill Feldman, Ivy Elkins, Zofia Piotrowska, et al.
Nature|December 22, 2007
Isolation of rare circulating tumour cells in cancer patients by microchip technologySunitha Nagrath, Lecia V Sequist, Shyamala Maheswaran, et al.
Nature Medicine|February 2, 2016
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAaron N Hata, Matthew J Niederst, Hannah L Archibald, et al.
Pageof 33